Bill
A 5374
Overview: Bill Number: A 5374, Title: Establishes a wound care kit and xylazine test strip distribution, Status: REFERRED TO ALCOHOLISM AND DRUG ABUSE, Introduced: February 27, 202
Overview: Bill Number: A 5374, Title: Establishes a wound care kit and xylazine test strip distribution, Status: REFERRED TO ALCOHOLISM AND DRUG ABUSE, Introduced: February 27, 2025
Purpose and Intent: This bill aims to address the growing public health crisis caused by the presence of xylazine, a dangerous veterinary sedative, in the illicit drug supply. The bill seeks to provide harm reduction resources to people who use drugs and reduce the harms associated with xylazine exposure.
Key Provisions:
- Requires the New York State Department of Health to establish a program for the distribution of wound care kits and xylazine test strips
- Specifies the contents of the wound care kits, which include items such as sterile gauze, antiseptic wipes, and naloxone
- Authorizes the distribution of the kits and test strips through various channels, including harm reduction organizations and community-based programs
Affected Parties and Impacts:
- People who use drugs, particularly those who may be exposed to xylazine, will have access to essential harm reduction tools to mitigate the risks associated with this dangerous substance
- Public health and community organizations will be able to provide these resources to vulnerable populations, potentially saving lives and reducing the burden on the healthcare system
Procedural and Timeline Considerations:
The bill has been referred to the Alcoholism and Drug Abuse Committee for further consideration. If passed, the Department of Health would be required to implement the distribution program within 180 days of the law's effective date.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
